RT Journal Article
SR Electronic
T1 MicroRNAs in lung diseases
JF Thorax
JO Thorax
FD BMJ Publishing Group Ltd and British Thoracic Society
SP 183
OP 184
DO 10.1136/thoraxjnl-2011-200532
VO 67
IS 2
A1 Pagdin, Tom
A1 Lavender, Paul
YR 2012
UL http://thorax.bmj.com/content/67/2/183.abstract
AB The advent of RNA sequencing technology has stimulated rapid advances in our understanding of the transcriptome, including discovery of the vast RNA complement generated by transcript splice variation and the expansion of our knowledge of non-coding RNAs. One non-coding RNA subtype, microRNAs (miRNAs), are particularly well studied, primarily because of their important roles as post-transcriptional gene regulators. The first miRNA was identified in the early 1990s and there are now thought to be around 1000 distinct miRNAs in man, with each cell type expressing a distinct repertoire. Increasing evidence has implicated miRNAs as having causative roles in a variety of lung diseases and has driven investigations into their potential as therapeutic targets.